From 24–27 October 2016, Melbourne Convention Centre will play host to International BioFest — a series of three major life sciences conferences taking place at the one time. [ + ]

The University of Melbourne's Bio21 Institute has announced a major collaborative agreement with Thermo Fisher Scientific, a world leader in serving science through the development and provision of cutting-edge technology. [ + ]

BioScience Managers has announced the launch of a new venture capital fund for Australia's innovative healthcare and biomedical research sectors. [ + ]

Australian and French scientists are developing a new potential way to detect and monitor breast cancer that could involve a simple blood test. [ + ]

OneVentures will lead a $15 million funding round for a promising new treatment for peanut allergy in children, developed at the Murdoch Childrens Research Institute. [ + ]

Allied Market Research has projected that the global defibrillator market will reach $15.61 billion by 2022. [ + ]

US and Australian scientists have developed a new method to estimate weakness in the Earth's outer layers. Their work will help explain and predict volcanic activity and earthquakes at a much smaller scale than previously possible. [ + ]

Australian scientists have identified a new type of immune cell that stays in the liver — liver-resident immune cells — guarding against malaria infection. [ + ]

The Turnbull government has announced the findings of the R&D Tax Incentive Review and is now encouraging feedback from stakeholders. [ + ]

Scottish scientists have discovered a way to replicate the regenerative power of stem cells in the lab, preventing them from differentiating over a prolonged period. [ + ]

CO2CRC, The University of Melbourne and Federation University Australia have opened emissions reduction laboratories aimed at providing clean, efficient energy for Australia. [ + ]

The Australian Academy of Science has announced Professor Barry Ninham AO FAA as the recipient of the 2017 Matthew Flinders Award and Lecture. [ + ]

Cystic fibrosis drug Bronchitol, from Pharmaxis, has been approved for marketing in Russia for the treatment of both paediatric and adult CF patients. [ + ]

UNSW researchers have answered a longstanding question that could lead to better drug delivery vehicles: how does a nanoparticle's shape affect its voyage through the cell? [ + ]

Oventus Medical has received clearance from the US FDA for the O2Vent T device, an oral appliance intended to alleviate snoring and obstructive sleep apnoea. [ + ]